SNUBH to launch Korea’s first int'l PSP Research and Treatment Centre | Healthcare Asia Magazine
, South Korea
Press photo from GemVax & KAEL via PR Newswire

SNUBH to launch Korea’s first int'l PSP Research and Treatment Centre

The centre will facilitate treatment, research, and the potential commercialisation of PSP therapies.

Seoul National University Bundang Hospital (SNUBH), along with CurePSP, Inc. and GemVax & KAEL Co., Ltd., is set to establish Korea's first International Progressive Supranuclear Palsy (PSP) Research and Treatment Centre.

The centre will leverage the organisations’ expertise and infrastructure to facilitate education, treatment, and research, as well as the potential commercialisation of therapies for PSP and other neurological conditions.

The centre will also address related conditions, including addiction-linked behavioural and neurological disorders, with a focus on substance abuse.

The initiative was formalised through a tripartite memorandum of understanding aimed at advancing research, treatment, and education for PSP and related neurological conditions.

Follow the link s for more news on

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!